Jean-Brice Veyrieres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jean-Brice Veyrieres has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jean Baptiste Morvan
Département d'oto-rhino-laryngologie et chirurgie cervico-faciale, hôpital national d'instruction des Armées Sainte-Anne, 83800 Toulon, France; École du Val de Grâce, Académie de santé des Armées, Paris, France
5 shared publications O. Mimouni
Service d’oto-rhino-laryngologie et chirurgie cervicofaciale, hôpital d’instruction des armées Sainte-Anne de Toulon, BP 600, 83800 Toulon Naval, France
4 shared publications- Olivier Cathelinaud
Service d’oto-rhino-laryngologie et chirurgie cervicofaciale, hôpital d’instruction des armées Sainte-Anne de Toulon, BP 600, 83800 Toulon Naval, France
4 shared publications P. Verdalle
Service d’oto-rhino-laryngologie et chirurgie cervicofaciale, hôpital d’instruction des armées Sainte-Anne de Toulon, BP 600, 83800 Toulon Naval, France
4 shared publicationsA.-T. N’guyen
Service d’anatomie et de cytologie pathologiques, hôpital d’instruction des armées Sainte-Anne de Toulon, BP 600, 83800 Toulon Naval, France
2 shared publicationsB. Fouet
Service d’anatomie et de cytologie pathologiques, hôpital d’instruction des armées Sainte-Anne de Toulon, BP 600, 83800 Toulon Naval, France
2 shared publications
Latest Publications
- Open Access
- 25 June 2014
- Published by Springer Nature in Critical Care
- Vol. 18 (3) , R131
Impairment of cardiac metabolism and sympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study
Introduction: Although aneurysmal subarachnoid hemorrhage (SAH) is often complicated by myocardial injury, whether this neurogenic cardiomyopathy is associated with the modification of cardiac metabolism is unknown. This study sought to explore, by positron emission tomography/computed tomography, the presence of altered cardiac glucose metabolism after SAH. Methods: During a 16-month period, 30 SAH acute phase patients underwent myocardial 18 F- fluorodesoxyglucose positron emission tomography (18F-FDGPET), 99mTc-tetrofosmin and 123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy, respectively, assessing glucose metabolism, cardiac perfusion, and sympathetic innervation. Patients with initial abnormalities were followed monthly for two months for 18F-FDG, and six months later for 123I-mIBG. Results: In this SAH population, acute cardiac metabolic disturbance was observed in 83% of patients (n = 25), and sympathetic innervation disturbance affected 90% (n = 27). Myocardial perfusion was normal for all patients. The topography and extent of metabolic defects and innervation abnormalities largely overlapped. Follow-up showed rapid improvement of glucose metabolism in one or two months. Normalization of sympathetic innervation was slower; only 27% of patients (n = 8) exhibited normal 123I-mIBG scintigraphy after six months. Presence of initial altered cardiac metabolism was not associated with more unfavorable cardiac or neurological outcomes. Conclusions: These findings support the hypothesis of neurogenic myocardial stunning after SAH. In hemodynamically stable acute phase SAH patients, cardiomyopathy is characterized by diffuse and heterogeneous 18F-FDG and 123I-mIBG uptake defect. Trial registration: Clinicaltrials.gov NCT01218191. Registered 6 October 2010.
- 25 June 2014
- Published by Springer Nature in Critical Care
- Vol. 18 (3) , R131
Open AccessImpairment of cardiac metabolism and sympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study
Introduction: Although aneurysmal subarachnoid hemorrhage (SAH) is often complicated by myocardial injury, whether this neurogenic cardiomyopathy is associated with the modification of cardiac metabolism is unknown. This study sought to explore, by positron emission tomography/computed tomography, the presence of altered cardiac glucose metabolism after SAH. Methods: During a 16-month period, 30 SAH acute phase patients underwent myocardial 18 F- fluorodesoxyglucose positron emission tomography (18F-FDGPET), 99mTc-tetrofosmin and 123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy, respectively, assessing glucose metabolism, cardiac perfusion, and sympathetic innervation. Patients with initial abnormalities were followed monthly for two months for 18F-FDG, and six months later for 123I-mIBG. Results: In this SAH population, acute cardiac metabolic disturbance was observed in 83% of patients (n = 25), and sympathetic innervation disturbance affected 90% (n = 27). Myocardial perfusion was normal for all patients. The topography and extent of metabolic defects and innervation abnormalities largely overlapped. Follow-up showed rapid improvement of glucose metabolism in one or two months. Normalization of sympathetic innervation was slower; only 27% of patients (n = 8) exhibited normal 123I-mIBG scintigraphy after six months. Presence of initial altered cardiac metabolism was not associated with more unfavorable cardiac or neurological outcomes. Conclusions: These findings support the hypothesis of neurogenic myocardial stunning after SAH. In hemodynamically stable acute phase SAH patients, cardiomyopathy is characterized by diffuse and heterogeneous 18F-FDG and 123I-mIBG uptake defect. Trial registration: Clinicaltrials.gov NCT01218191. Registered 6 October 2010.
- 1 December 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (12) , 3965-3972
A threshold value in Shear Wave elastography to rule out malignant thyroid nodules: A reality?
- 1 December 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (12) , 3965-3972
A threshold value in Shear Wave elastography to rule out malignant thyroid nodules: A reality?
- 31 December 2011
- Published by Elsevier in Feuillets de Radiologie
- Vol. 51 (6) , 358
Douleur de nuque ictale
- 31 December 2011
- Published by Elsevier in Feuillets de Radiologie
- Vol. 51 (6) , 358
Douleur de nuque ictale
- 1 December 2011
- Published by Elsevier in Feuillets de Radiologie
- Vol. 51 (6) , 336-340
Douleur de nuque ictale
- 1 December 2011
- Published by Elsevier in Feuillets de Radiologie
- Vol. 51 (6) , 336-340
Douleur de nuque ictale
- 30 November 2011
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 128 (5) , 262-265
Solitary fibrous tumour of the larynx: A case report
- 30 November 2011
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 128 (5) , 262-265
Solitary fibrous tumour of the larynx: A case report
- 6 November 2011
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 128 (5) , 304-307
Tumeur fibreuse solitaire du larynx – À propos d’un cas
- 6 November 2011
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 128 (5) , 304-307
Tumeur fibreuse solitaire du larynx – À propos d’un cas
- 30 June 2011
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 128 (3) , 147-149
Perforation of the piriform sinus after sneezing with cervical subcutaneous emphysema and pneumomediastinum
- 30 June 2011
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 128 (3) , 147-149
Perforation of the piriform sinus after sneezing with cervical subcutaneous emphysema and pneumomediastinum
- 1 June 2011
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 128 (3) , 165-168
Perforation du sinus piriforme après un éternuement avec emphysème sous-cutané cervical et pneumomédiastin
- 1 June 2011
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 128 (3) , 165-168
Perforation du sinus piriforme après un éternuement avec emphysème sous-cutané cervical et pneumomédiastin